115
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Differences in the Association Among the Vitamin D Concentration, Dietary Macronutrient Consumption, and Metabolic Syndrome Depending on Pre- and Postmenopausal Status in Korean Women: A Cross-Sectional Study

ORCID Icon, ORCID Icon & ORCID Icon
Pages 3601-3609 | Published online: 09 Oct 2020

Figures & data

Table 1 General Characteristics

Table 2 Metabolic Syndrome-Related Variables and Dietary Macronutrient Consumption According to 25-Hydroxyvitamin D Concentration

Table 3 Metabolic Syndrome-Related Variables and Dietary Macronutrient Consumption According to Menopausal Status and 25-Hydroxyvitamin D Concentration

Figure 1 Adjusted odds ratio for obesity and metabolic syndrome according to menopausal status and 25-hydroxyvitamin D concentration. Obesity was defined as BMI ≥25.0 kg/m2 by the Korean Society for the Study of Obesity. Metabolic syndrome was defined if ≥ 3 following diagnostic criteria by the modified National Cholesterol Education Program/Adult Treatment Panel III: 1) WC ≥85 cm according to the Korean Society for the Study of Obesity, 2) TGs ≥150 mg/dL or receiving treatment for high TGs, 3) HDL-C <50 mg/dL or receiving treatment for low HDL-C, 4) BP ≥130/85 mmHg or receiving treatment for high BP, and 5) FG ≥100 mg/dL or receiving treatment for hyperglycemia. The odds ratios (95% confidence intervals) were calculated in reference to a serum vitamin D concentration ≥50 nmol/L using multivariate logistic regression adjusting for age, education level, household income, marital status, residential region, subjective stress level, dietary supplement consumption, smoking status, alcohol consumption status, and regular exercise (* p<0.05, ** p<0.01).

Figure 1 Adjusted odds ratio for obesity and metabolic syndrome according to menopausal status and 25-hydroxyvitamin D concentration. Obesity was defined as BMI ≥25.0 kg/m2 by the Korean Society for the Study of Obesity. Metabolic syndrome was defined if ≥ 3 following diagnostic criteria by the modified National Cholesterol Education Program/Adult Treatment Panel III: 1) WC ≥85 cm according to the Korean Society for the Study of Obesity, 2) TGs ≥150 mg/dL or receiving treatment for high TGs, 3) HDL-C <50 mg/dL or receiving treatment for low HDL-C, 4) BP ≥130/85 mmHg or receiving treatment for high BP, and 5) FG ≥100 mg/dL or receiving treatment for hyperglycemia. The odds ratios (95% confidence intervals) were calculated in reference to a serum vitamin D concentration ≥50 nmol/L using multivariate logistic regression adjusting for age, education level, household income, marital status, residential region, subjective stress level, dietary supplement consumption, smoking status, alcohol consumption status, and regular exercise (* p<0.05, ** p<0.01).

Table 4 Association of the Combined Effect the Menopausal Status and 25-Hydroxyvitamin D Concentration on Obesity and Metabolic Syndrome According to Dietary Macronutrient Consumption